Background. A 57-year-old woman presented to the emergency department at a community hospital with a 2-month history of fatigue and right-sided flank and abdominal pain. Noncontrast CT of the abdomen ...

Refinements in nephrectomy procedures have dramatically improved the safety of these procedures. Data from a prospective study of 140 patients with kidney cancer confirm that laparoscopic nephrectomy ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

WASHINGTON, D.C. (May 15, 2011)––New techniques in science and technology allow the medical community to continually improve patient care and experience, but as these new procedures are introduced, ...

An economic analysis of axitinib and sorafenib for second-line treatment of cytokine-refractory patients with advanced renal cell carcinoma in the United States (US). This is an ASCO Meeting Abstract ...

Surgeons specializing in laparoscopic procedures have successfully removed a patient's kidney by performing a unique nephrectomy entirely through the belly button. Surgeons specializing in ...

*Refers to the latest 2 years of stltoday.com stories. Cancel anytime. Within the last 10 years, minimally invasive surgery, also known as "keyhole" or "band-aid" surgery, has become an alternative to ...

Operative techniques for donor nephrectomy, discussed at the ASTS Winter Symposium, will not be described in detail here. Currently, there are 2 operative approaches to live donor nephrectomy: the ...

Jihad Kaouk, MD, Director of the Center for Laparoscopic and Robotic Surgery, and his team performed the world's first completely transvaginal nephrectomy on March 13, 2009. Jihad Kaouk, MD, Director ...

a Mean creatinine after 10 years of follow-up. b Median creatinine after median 24 months of follow-up. NR, not reported. Nephron-sparing surgery (NSS) for renal cell carcinoma has the advantage of ...

A phase II study of S-1 for the treatment of cytokine and/or tyrosine-kinase inhibitor (TKI) refractory metastatic renal cell carcinoma: Updated results. Background: Laparoscopic and robotic partial ...